SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-20-007286
Filing Date
2020-04-29
Accepted
2020-04-28 17:41:47
Documents
64
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 992629
2 ex4-6.htm EX-4.6 27378
3 ex23-1.htm EX-23.1 5458
4 ex31-1.htm EX-31.1 22145
5 ex31-2.htm EX-31.2 20447
6 ex32-1.htm EX-32.1 11400
7 ex99-1.htm EX-99.1 15415
8 ex23-1_002.jpg GRAPHIC 92339
9 ex23-1_001.jpg GRAPHIC 22085
  Complete submission text file 0001493152-20-007286.txt   4043520

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE FILE ptix-20191231.xml EX-101.INS 538299
11 XBRL SCHEMA FILE ptix-20191231.xsd EX-101.SCH 47287
12 XBRL CALCULATION FILE ptix-20191231_cal.xml EX-101.CAL 50028
13 XBRL DEFINITION FILE ptix-20191231_def.xml EX-101.DEF 177579
14 XBRL LABEL FILE ptix-20191231_lab.xml EX-101.LAB 342787
15 XBRL PRESENTATION FILE ptix-20191231_pre.xml EX-101.PRE 258824
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51353 | Film No.: 20826363
SIC: 7389 Services-Business Services, NEC